GT Biopharma Inc. (GTBP) Announces Agreement with a Major Pharmaceutical Company

GT Biopharma Inc. Announces Agreement with a Major Pharmaceutical Company to Study…

GT Biopharma Inc. (GTBP) Announces 50% Enrollment in Proof-Of-Concept Clinical Trial For Its Novel Treatment For Motion Sickness

GT Biopharma Inc. (GTBP) (Euronext Paris: GTBP.PA) announced today that the Proof-of-Concept…

GT Biopharma (OXISD) Announces Development Plan For Non-Opioid Neuropathic Pain Treatment “PainBrake”

LOS ANGELES, CA / ACCESSWIRE / September 11, 2017 / GT Biopharma…

GT Biopharma (OXISD) Hires Former Pfizer CMO/Vice President and Senior Director of Oncology Research as CMO

LOS ANGELES, CA / ACCESSWIRE / September 7, 2017 / GT Biopharma…